| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/25/2013 | CN103463048A Application of Lycojaponicumin A in medicaments for promoting small intestine peristalsis |
| 12/25/2013 | CN103463047A Application of Lycojaponicumin B in medicine for treating bile duct cancer |
| 12/25/2013 | CN103463046A Application of Lycojaponicumin A in drugs for treating colorectal cancer |
| 12/25/2013 | CN103463045A Application of Lycojaponicumin A in drugs for treating ileocecal carcinoma |
| 12/25/2013 | CN103463044A Application of Lycojaponicumin A in drugs for treating skin cancer |
| 12/25/2013 | CN103463043A Application of Lycojaponicumin A in medicaments for treating lung cancer |
| 12/25/2013 | CN103463042A Application of Lycojaponicumin A in drugs for treating prostatic cancer |
| 12/25/2013 | CN103463041A Application of Lycojaponicumin B in medicine for treating bladder cancer |
| 12/25/2013 | CN103463040A Application of Lycojaponicumin A in drugs for treating hemorrhagic fever renal syndrome |
| 12/25/2013 | CN103463039A Application of Lycojaponicumin B in medicine for preventing lung cancer metastasis |
| 12/25/2013 | CN103463038A Application of Lycojaponicumin A in insulinotropic hormone excretion medicaments |
| 12/25/2013 | CN103463037A Application of Lycojaponicumin A in antibacterial medicaments |
| 12/25/2013 | CN103463036A Application of Lycojaponicumin B in monoamine oxidase inhibitor medicine |
| 12/25/2013 | CN103463035A Application of Lycojaponicumin B in anti-herpes virus medicine |
| 12/25/2013 | CN103463034A Application of Lycojaponicumin B to medicament for treating oophoroma |
| 12/25/2013 | CN103463033A Application of Lycojaponicumin B in medicine for treating gastric cancer |
| 12/25/2013 | CN103463032A Application of Lycojaponicumin A in medicine for treating pancreatic cancer |
| 12/25/2013 | CN103463031A Application of Lycojaponicumin B in medicine for promoting insulin secretion |
| 12/25/2013 | CN103463030A Application of Lycojaponicumin B in medicine for treating influenza virus A |
| 12/25/2013 | CN103463029A Application of Lycojaponicumin B in human fungus resisting medicine |
| 12/25/2013 | CN103463028A Application of Lycojaponicumin A in anti-influenza A virus medicaments |
| 12/25/2013 | CN103463027A Application of Lycojaponicumin A in medicine for treating laryngocarcinoma |
| 12/25/2013 | CN103463026A Application of Lycojaponicumin B in medicine for treating dengue virus infection |
| 12/25/2013 | CN103463025A Application of Lycojaponicumin B in medicine for treating lung cancer |
| 12/25/2013 | CN103463024A Application of Lycojaponicumin B in medicine for treating kidney cancer |
| 12/25/2013 | CN103463023A Application of Lycojaponicumin B in helicobacter pylori resistant medicine |
| 12/25/2013 | CN103463022A Application of Lycojaponicumin B in medicine for treating ileocecum cancer |
| 12/25/2013 | CN103463021A Application of Lycojaponicumin B in medicine for treating yellow fever virus infection |
| 12/25/2013 | CN103463020A Application of Lycojaponicumin A in medicine for treating kidney cancer |
| 12/25/2013 | CN103463019A Applications of Lycojaponicumin B in medicine for treating leukemia |
| 12/25/2013 | CN103463018A Application of Lycojaponicumin B in preparation of medicine for treating hemorrhagic fever with renal syndrome |
| 12/25/2013 | CN103463017A Application of Lycojaponicumin B in preparation of medicines for treating pancreatic cancer |
| 12/25/2013 | CN103463016A Application of Lycojaponicumin A in medicine for treating endometrial cancer |
| 12/25/2013 | CN103463015A Application of imidafenacin in preparation of medicine for treating hypertension |
| 12/25/2013 | CN103463014A Compound alpha-ketoacid tablet and preparation method thereof |
| 12/25/2013 | CN103463013A Preparation process of high-concentration compound amino acid injection |
| 12/25/2013 | CN103463012A Application of fluevirosines A in preparation of medicine inhibiting tubercle bacillus |
| 12/25/2013 | CN103463011A Application of fluevirosines A in preparation of medicine inhibiting liver fibroblast proliferation |
| 12/25/2013 | CN103463010A Application of fluevirosines A in preparation of monoamine oxidase (MAO) inhibitor |
| 12/25/2013 | CN103463009A Application of racemosins A in preparation of medicine treating acute renal failure |
| 12/25/2013 | CN103463008A Application of racemosins A in preparation of medicine treating myocardial ischemia |
| 12/25/2013 | CN103463007A Application of racemosins A in preparation of medicine treating rhinitis |
| 12/25/2013 | CN103463006A Application of racemosins A in preparation of medicine treating or preventing chronic heart failure |
| 12/25/2013 | CN103463005A Application of racemosins A in preparation of medicine treating or preventing renal fibrosis |
| 12/25/2013 | CN103463004A Application of racemosins A in preparation of medicine treating renal insufficiency |
| 12/25/2013 | CN103463003A Application of racemosins A in preparation of medicine treating ischemic brain injury |
| 12/25/2013 | CN103463002A Application of racemosins A in preparation of medicine treating hemorrhagic fever with renal syndrome |
| 12/25/2013 | CN103463001A Application of Neonectrolide A to preparation of medicament for treating acute gout |
| 12/25/2013 | CN103463000A Application of Neonectrolide A in preparing medicament for treating renal insufficiency |
| 12/25/2013 | CN103462999A Application of Neonectrolide A in preparing medicament for treating rhinitis |
| 12/25/2013 | CN103462998A Application of Neonectrolide A in preparing medicament for treating or preventing dental ulcer |
| 12/25/2013 | CN103462997A Application of Neonectrolide A in preparing medicament for treating or preventing acute heart failure |
| 12/25/2013 | CN103462996A Application of Neonectrolide A in preparing medicament for treating acute renal failure |
| 12/25/2013 | CN103462995A Application of Neonectrolide A in preparing a medicament for treating hemorrhagic fever with renal syndrome |
| 12/25/2013 | CN103462994A Application of Neonectrolide A in preparing medicament for treating ischemic brain injury |
| 12/25/2013 | CN103462993A Application of Aphanamgrandiol A in preparation of human anti-fungal medicaments |
| 12/25/2013 | CN103462992A Application of Aphanamgrandiol A in preparation of medicaments for treating and preventing renal fibrosis |
| 12/25/2013 | CN103462991A Application of Aphanamgrandiol A in preparation of anti-bacterial medicaments |
| 12/25/2013 | CN103462990A Application of Aphanamgrandiol A in preparation of anti-depressant medicaments |
| 12/25/2013 | CN103462989A Application of Lycojaponicumin B in preparation of medicines for resisting human body fungi |
| 12/25/2013 | CN103462988A Application of artesunate in preparation of medicines for treating infantile hemangioma |
| 12/25/2013 | CN103462987A Application of epigallocatechin gallate stearates and medicinal composition for treating psoriasis |
| 12/25/2013 | CN103462986A Application of spirooliganones B in preparation of medicine reducing blood glucose |
| 12/25/2013 | CN103462985A Application of spirooliganones B in preparation of medicine inhibiting platelet aggregation |
| 12/25/2013 | CN103462984A Application of spirooliganones B in preparation of medicine inhibiting liver fibroblast proliferation |
| 12/25/2013 | CN103462983A Application of spirooliganones B in preparation of monoamine oxidase (MAO) inhibitor |
| 12/25/2013 | CN103462982A Application of spirooliganones B in preparation of medicine inhibiting bacteria |
| 12/25/2013 | CN103462981A Application of spirooliganones B in preparation of medicine promoting small intestine peristalsis |
| 12/25/2013 | CN103462980A Application of spirooliganones B in preparation of medicine inhibiting tubercle bacillus |
| 12/25/2013 | CN103462979A Application of spirooliganones B in preparation of medicine inhibiting helicobacter pylori |
| 12/25/2013 | CN103462978A Application of spirooliganones B in preparation of medicine treating acute gout |
| 12/25/2013 | CN103462977A Application of 4', 5, 7-genistein in preparing rotavirus resisting medicine |
| 12/25/2013 | CN103462976A Application of Incarviatone A in anti-tubercle bacillus medicaments |
| 12/25/2013 | CN103462975A Inclusion compound of mangiferin and alkaline cyclodextrin |
| 12/25/2013 | CN103462974A Application of Incarviatone A in medicaments for treating ovarian cancer |
| 12/25/2013 | CN103462973A Application of Incarviatone A in medicaments for treating lung cancer |
| 12/25/2013 | CN103462972A Application of Incarviatone A in anti-lung cancer metastasis medicaments |
| 12/25/2013 | CN103462971A Application of Incarviatone A in medicaments for treating kidney cancer |
| 12/25/2013 | CN103462970A Application of Incarviatone A in medicaments for treating dengue virus infection |
| 12/25/2013 | CN103462969A Application of Incarviatone A in medicaments for treating breast cancer |
| 12/25/2013 | CN103462968A Application of Incarviatone A in antibacterial medicaments |
| 12/25/2013 | CN103462967A Application of Incarviatone A in anti-herpes virus medicaments |
| 12/25/2013 | CN103462966A Application of Incarviatone A in medicaments for treating colorectal cancer |
| 12/25/2013 | CN103462965A Application of Incarviatone A in insulinotropic hormone excretion medicaments |
| 12/25/2013 | CN103462964A Application of Incarviatone A in medicaments for treating bile duct cancer |
| 12/25/2013 | CN103462963A Application of Incarviatone A in medicaments for treating yellow fever virus infection |
| 12/25/2013 | CN103462962A Application of Incarviatone A in medicaments for treating leukemia |
| 12/25/2013 | CN103462961A Application of Incarviatone A in medicaments for treating bladder cancer |
| 12/25/2013 | CN103462960A Application of Incarviatone A in medicaments for treating prostatic cancer |
| 12/25/2013 | CN103462959A Application of Incarviatone A in medicaments for treating liver cancer |
| 12/25/2013 | CN103462958A Application of Incarviatone A in medicaments for treating tongue cancer |
| 12/25/2013 | CN103462957A New application of isorhamnetin |
| 12/25/2013 | CN103462956A Application of Nardoaristolones A in preparation of medicaments for increasing erythrocytes |
| 12/25/2013 | CN103462955A Application of Nardoaristolones A in preparation of medicaments for treating stomach cancer |
| 12/25/2013 | CN103462954A Application of Nardoaristolones A in preparation of medicaments for treating skin cancer |
| 12/25/2013 | CN103462953A Application of Nardoaristolones A in preparation of medicaments for treating tongue cancer |
| 12/25/2013 | CN103462952A Application of Nardoaristolones A in preparation of medicaments for treating ovarian cancer |
| 12/25/2013 | CN103462951A Application of scopariusins in preparation of medicine treating or preventing canker sore |
| 12/25/2013 | CN103462950A Application of scopariusins in preparation of medicine treating acute gout |
| 12/25/2013 | CN103462949A Application of Scopariusins in preparing medicine for treating and promoting small intestine peristalsis |